Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, et al. N Engl J Med 2022;386:316-326.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, et al. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:316-326.
PMID: 35081280